Hikal Ltd Hits New 52-Week Low at Rs. 245 Amid Ongoing Decline

Hikal, a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs. 245 on October 9, 2025. This decline marks a significant downturn for the stock, which has underperformed its sector by 2.85% today. Over the past five days, Hikal has seen a consecutive fall, resulting in a total decline of 3.82% during this period.
The stock's performance is reflected in its trading metrics, as it is currently below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The intraday low of Rs. 245 represents a 2.12% decrease from the previous close. Over the past year, Hikal has experienced a substantial decline of 28.19%, contrasting sharply with the Sensex's modest gain of 0.78%.

Financial indicators reveal a challenging landscape for Hikal, with a reported operating profit growth rate of -2.51% over the last five years and a significant drop in profit after tax for the latest quarter. The company's cash and cash equivalents have also reached a low of Rs. 18.00 crore, highlighting ongoing financial pressures.